Immune microenvironment of penile squamous cell carcinoma: HPV-driven versus HPV-independent
Academia Immunity and Disease · 20.11.2026 · 2 (4)
DOI: 10.20935/acadimmunodis8587 ↗Kurz gefasst
Fachartikel in der Zeitschrift Academia Immunity and Disease, online erschienen am 20.11.2026. Verfasst von Paola Britos und 1 weiteren Autor:innen. Die Arbeit nennt 34 Literaturangaben.
Abstract (Originalsprache)
Penile squamous cell carcinoma (pSCC) is rare, with human papillomavirus (HPV)–driven and HPV-independent pathways that may shape the tumor immune microenvironment (TIME). We conducted an integrative review (Whittemore and Knafl) reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 statement. Structured searches of Europe PMC and MEDLINE (13 August 2026), plus an authors’ curated bibliography, yielded 318 unique records after deduplication. Two reviewers independently screened the records; data for the 24 tabulated sources were extracted and appraised (Mixed Methods Appraisal Tool, MMAT v.2018) by two reviewers, and the four included studies co-authored by A.C. by P.B. alone. Synthesis was narrative; no meta-analysis was performed. In total, 121 reports (119 unique studies) were included; original research predominated ( n = 83), and HPV stratification was available in 76/121. Programmed death-ligand 1 (PD-L1; n = 86), programmed cell death protein 1 (PD-1; n = 61), and cluster of differentiation 8 (CD8; n = 47) were the most frequent TIME markers. The most reproducible HPV–TIME contrast was higher PD-L1 in HPV-independent tumors; HPV-positive tumors more often showed selected effector, myeloid, or tertiary lymphoid structure (TLS) features, but unsupervised immunophenotypes were not reducible to HPV status alone. Diffuse or high tumor PD-L1, low lymphocytic infiltrate, adverse myeloid spatial patterns, and elevated neutrophil-to-lymphocyte ratio (NLR) recurred as adverse signals. In real-world immune checkpoint inhibitor (ICI) series, the objective response rate was 13% overall and 35% in lymph-node–only metastases. HPV defines a biological axis within pSCC TIME—most clearly PD-L1 enrichment in HPV-independent disease—but is not a complete immune classifier. ICI activity in advanced pSCC is clinically meaningful yet uncommon; biomarker-guided selection remains hypothesis-generating.
Zitieren
APA
Britos, P., & Chaux, A. (2026). Immune microenvironment of penile squamous cell carcinoma: HPV-driven versus HPV-independent. Academia Immunity and Disease, 2(4). https://doi.org/10.20935/acadimmunodis8587
Vancouver
Britos P, Chaux A. Immune microenvironment of penile squamous cell carcinoma: HPV-driven versus HPV-independent. Academia Immunity and Disease. 2026;2(4). doi:10.20935/acadimmunodis8587
BibTeX
@article{Britos2026,
author = {Britos, Paola and Chaux, Alcides},
title = {Immune microenvironment of penile squamous cell carcinoma: HPV-driven versus HPV-independent},
journal = {Academia Immunity and Disease},
year = {2026},
volume = {2},
number = {4},
doi = {10.20935/acadimmunodis8587}
}
EUVIMED